Faculty profile
Aymeric Ravel-Chapuis
Back to facultyResearch
Read how they describe their research on their University of Ottawa profile.
Latest papers
A bitter melon natural compound ameliorates the myotonic dystrophy type 1 skeletal muscle phenotype in a sex-specific manner.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
Exercise mimetics as unexplored therapeutics for treating depression.
Molecular psychiatry · 2026
Disruptions of cell signaling pathways in myotonic dystrophy type 1 skeletal muscle, their pathogenic impact, and potential for combinatorial therapeutics.
The Journal of biological chemistry · 2026 · first author
Latest funding
- $1,000,000
NMD4C: the neuromuscular network for Canada
CIHR · 2023 · Co-investigator
- $481,950
Pharmacologic and RNAi Screens for Myotonic Dystrophy Type 1 foci modulators; towards Novel DM1 therapeutic approaches
CIHR · 2018 · Co-investigator
28 publications.
A bitter melon natural compound ameliorates the myotonic dystrophy type 1 skeletal muscle phenotype in a sex-specific manner.
Atieh SA, Fahmi C, Liu J, Tang C, Ye Y, Ravel-Chapuis A, Jasmin BJ
Exercise mimetics as unexplored therapeutics for treating depression.
Fabiano N, Fiedorowicz JG, Ravel-Chapuis A, Jasmin BJ
Disruptions of cell signaling pathways in myotonic dystrophy type 1 skeletal muscle, their pathogenic impact, and potential for combinatorial therapeutics.
Ravel-Chapuis A, Atieh SA, Fahmi C, Jasmin BJ
Dystrophic Skeletal Muscle Phenotypes Can Be Horizontally Transferred via Fecal Microbiome Transplantations.
Butcher J, Gosse JT, Gobin J, Ravel-Chapuis A, Jasmin BJ, Stintzi A
Probing the extent of importin-α targeting of the TAF8 NLS by eliminating its cationic net-charge.
Abdoli A, Yang Z, Odeh-Ahmed A, Bednova O, Lemieux B, Dawe L, Ravel-Chapuis A, Lavigne P, Zeytuni N, Leyton JV
The AMPK allosteric activator MK-8722 improves the histology and spliceopathy in myotonic dystrophy type 1 (DM1) skeletal muscle.
Ravel-Chapuis A, Fahmi C, Gobin J, Jasmin BJ
Changes in Physiopathological Markers in Myotonic Dystrophy Type 1 Skeletal Muscle: A 3-Year Follow-up Study.
Roussel MP, Ravel-Chapuis A, Gobin J, Jasmin BJ, Leduc-Gaudet JP, Gagnon C, Duchesne E
Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model.
Neault N, Ravel-Chapuis A, Baird SD, Lunde JA, Poirier M, Staykov E, Plaza-Diaz J, Medina G, Abadía-Molina F, Jasmin BJ, MacKenzie AE
Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner.
Misquitta NS, Ravel-Chapuis A, Jasmin BJ
Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-β via Smad3 acetylation.
Osseni A, Ravel-Chapuis A, Belotti E, Scionti I, Gangloff YG, Moncollin V, Mazelin L, Mounier R, Leblanc P, Jasmin BJ, Schaeffer L
NMD4C: the neuromuscular network for Canada
Principal investigators: Lochmüller, Hanns; Osman, Homira; Brais, Bernard; Campbell, Craig Gordon N; Chang, Natasha C; Dowling, James; Gagnon, Cynthia; Gonorazky, Hernan D; Hodgkinson, Victoria; Karamchandani, Jason; Korngut, Lawrence W; Kothary, Rashmi K; Mah, Jean K; O'Connell, Colleen; Patten, Kessen; Rossi, Fabio M; Schellenberg, Kerri; Selby, Kathryn A; Warman Chardon, Jodi
Keywords: Clinical Trial Networks; Networks; Neuromuscular Disease; Open Science; Patient Partnerships; Preclinical Research Resources; Training And Education; Translational Research
Pharmacologic and RNAi Screens for Myotonic Dystrophy Type 1 foci modulators; towards Novel DM1 therapeutic approaches
Principal investigators: Mackenzie, Alexander E; Jasmin, Bernard J
Keywords: Cell Phenotype; Drug Screen; Muscular Dystrophy
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Biochemistry, Microbiology and Immunology
- School of Pharmaceutical Sciences
- Microbiologie et d'infectiologie
- Ecole de réadaptation
- Pathology and Laboratory Medicine
- Cellular and Molecular Medicine
- Anatomy and Biology
- Other
Co-authors at University of Ottawa, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Elise Duchesne
Faculty
2 shared papers, latest 2024
Jean Michaud
Pathology and Laboratory Medicine
1 shared papers, latest 2017
Martin Pelchat
Biochemistry, Microbiology and Immunology
1 shared papers, latest 2016
Benoit Chabot
Microbiologie et d'infectiologie
1 shared papers, latest 2016
Jean-Marc Renaud
Cellular and Molecular Medicine
1 shared papers, latest 2017
Silvia Penuela
Department of Anatomy & Cell Biology
1 shared papers, latest 2018
Cynthia Gagnon
Ecole de réadaptation
1 shared papers, latest 2024
Pierre Lavigne
Médecine
1 shared papers, latest 2025
Cynthia Gagnon
Faculty
1 shared papers, latest 2024
Alain Stintzi
Biochemistry, Microbiology and Immunology
1 shared papers, latest 2025
Natalie Zeytuni
Anatomy and Biology
1 shared papers, latest 2025
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.